Aug 1 |
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
|
Jul 25 |
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
|
Jul 9 |
Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia
|
Jul 8 |
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
|
Jul 8 |
Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences
|
Jun 10 |
Arcus Completes Enrollment in Phase 3 Trial of Domvanalimab-Containing Regimen for Stomach Cancer
|
Jun 10 |
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
|
Jun 7 |
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?
|
Jun 6 |
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
Jun 3 |
Gilead, Arcus combo significantly reduces death risk in colorectal cancer
|